Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 28:12:740048.
doi: 10.3389/fimmu.2021.740048. eCollection 2021.

Safety of Influenza A H1N1pdm09 Vaccines: An Overview of Systematic Reviews

Lene Kristine Juvet  1 , Anna Hayman Robertson  1 , Ida Laake  1 , Siri Mjaaland  1 , Lill Trogstad  1
Affiliations

Safety of Influenza A H1N1pdm09 Vaccines: An Overview of Systematic Reviews

Lene Kristine Juvet et al. Front Immunol. .

Abstract

Background: In 2009, a new influenza A H1N1 virus emerged causing a global pandemic. A range of monovalent influenza A H1N1pdm09 vaccines with or without adjuvants were developed. After the mass vaccination campaigns safety concerns related to H1N1pdm09 vaccines were reported. More than a decade later, reported AEFIs are still under scrutiny. We performed a systematic review aiming to synthesize the evidence on the safety of the H1N1pdm09 vaccines on reported outcomes from existing systematic reviews.

Methods: Four electronic databases, PubMed, EMBASE, Epistimonikos and the Cochrane Database of Systematic Reviews were searched for articles on H1N1pdm09 vaccination published from 2009 to January 2021. Systematic reviews assessing short- or long-term adverse events after H1N1pdm09 vaccination were considered for inclusion. Data was extracted from all selected reviews. Outcomes were grouped and results from each included review were presented narratively and in tables.

Results: 16 systematic reviews met the inclusion criteria. Reported outcomes were short-term events (3 reviews), fetal/pregnancy outcomes (8 reviews), Guillain-Barré syndrome (GBS) (4 reviews), narcolepsy (2 reviews) demyelinating diseases (1 review based on one study only) and inflammatory bowel disease (IBD) (1 review). Short-term serious adverse events were rare, 3 cases amongst 16725 subjects in 18 randomized controlled trials (0.018%). No deaths were reported. The risks of local events were generally higher for adjuvanted vaccines as compared to unadjuvanted vaccines. Maternal H1N1pdm09 vaccination in any trimester was not associated with an increase in preterm birth, small for gestational age, congenital malformations or fetal death. For GBS, results were conflicting. The main systematic review on narcolepsy found a 5-14-fold increased risk in children, and a 2-7- fold increased risk in adults after vaccination with Pandemrix. The attributable risk of narcolepsy one year after vaccination was 1 case per 18 400 vaccine doses in children/adolescents, and 1 case per 181 000 vaccine doses in adults.

Conclusion: Adjuvanted vaccines had more local but not serious adverse events compared to unadjuvanted vaccines. Vaccination with Pandemrix was strongly associated with narcolepsy, particularly in children. No increased risks of pregnancy outcomes were seen after pandemic vaccination. The findings on GBS were inconclusive.

Keywords: H1N1pdm09 vaccination; adverse events; influenza vaccines; pandemic vaccines; safety.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Study selection, PRISMA flow chart.
See this image and copyright information in PMC

References

    1. 2009 H1N1 Pandemic (H1N1pdm09 virus) . Centers for Disease Control and Prevention (CDC) . Available at: https://www.cdc.gov/flu/pandemic-resources/2009-h1n1-pandemic.html (Accessed June 30, 2021).
    1. Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S, et al. Estimates of Global Seasonal Influenza-Associated Respiratory Mortality: A Modelling Study. Lancet (2018) 391:1285–300. doi: 10.1016/S0140-6736(17)33293-2 - DOI - PMC - PubMed
    1. The ANZIC Influenza Investigators and Australasian Maternity Outcomes Surveillance System. Critical Illness Due to 2009 A/H1N1 Influenza in Pregnant and Postpartum Women: Population Based Cohort Study. BMJ (2010) 340:c1279. doi: 10.1136/bmj.c1279 - DOI - PMC - PubMed
    1. WHO . New Data on Narcolepsy Following the 2009 Pandemic Influenza Vaccine, in: The Global Advisory Comittee of Vaccine Safety (2017). Available at: https://www.who.int/groups/global-advisory-committee-on-vaccine-safety/t... (Accessed June 30, 2021).
    1. Kurz X, Domergue F, Slattery J, Segec A, Szmigiel A, Hidalgo-Simon A. Safety Monitoring of Influenza A/H1N1 Pandemic Vaccines in EudraVigilance. Vaccine (2011) 29:4378–87. doi: 10.1016/j.vaccine.2011.04.005 - DOI - PubMed

Publication types

MeSH terms